6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin

Romain Didier , Marie-Claude Morice , Paul Barragan , Arif A.L. Noryani , Hussam A. Noor , Talib Majwal , Thomas Hovasse , Philippe Castellant , Michel Schneeberger , Jean-Luc Maillard , Bressolette Erwan , Jaroslaw Wojcik , Nicolas Delarche , Didier Blanchard , Bernard Jouve , Olivier Ormezzano (1) , Franck Paganelli (2) , Gilles Levy , Joel Sainsous , Didier Carrie , Alain Furber , Jacques Berland , Olivier Darremont , Herve Le Breton , Anne Lyuycx-Bore , Antoine Gommeaux , Claude Cassat , Alain Kermarrec , Pierre Cazaux , Philippe Druelles , Raphael Dauphin , J. Armengaud , Patrick Dupouy , Didier Champagnac , Patrick Ohlmann , Hakim Benamer , Robert Kiss , Irme Ungi , Martine Gilard

1 CHU - Centre Hospitalier Universitaire [Grenoble]
2 VRCM - Vascular research center of Marseille

Domains: Life Sciences [q-bio]; Life Sciences [q-bio]; Human health and pathology

Romain Didier, Marie-Claude Morice, Paul Barragan, Arif A.L. Noryani, Hussam A. Noor, et al.. 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin. JACC: Cardiovascular Interventions, 2017, 10 (12), pp.1202 - 1210. ⟨10.1016/j.jcin.2017.03.049⟩. ⟨hal-01788783⟩